our investment thesis
focused portfolio
concentrated in attractive specialties with strong competitive positions
differentiated technologies
Formulation expertise and application knowledge that solve customer challenges
attractive end markets
exposure to resilient, growing markets with favorable long-term trends
innovation-led growth
sustained investment in innovation to create high-value, customer-centric solutions
disciplined capital allocation
balanced approach to reinvest, return capital and pursue value accretive M&A
Ashland at a glance (tm)
~$2.1B
net sales
~19%
adjusted EBITDA margin1
~2,900
employees worldwide
~100
countries served
100+
years of innovation
strong balance sheet
ample liquidity and financial flexibility
1Sales, adjusted EBITDA and adjusted EBITDA margins were all impacted by our Portfolio Optimization initiatives. Actions such as curtailing or divesting lower margin products and rationalizing product lines reduced sales by approximately $208 million and adjusted EBITDA by $45 million, while improving adjusted EBITDA margins by 30 basis points in fiscal year 2025 compared to 2024.
